Parul Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 07-12-2024
- Paid Up Capital ₹ 0.10 M
as on 07-12-2024
- Company Age 3 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 881.34%
(FY 2023)
- Profit 223.04%
(FY 2023)
- Ebitda 212.25%
(FY 2023)
- Net Worth 310.89%
(FY 2023)
- Total Assets 244.54%
(FY 2023)
About Parul Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Parul Patel and Devanshu Patel serve as directors at the Company.
- CIN/LLPIN
U24230GJ2021PTC120280
- Company No.
120280
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Feb 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Parul Pharmaceuticals Private Limited offer?
Parul Pharmaceuticals Private Limited offers a wide range of products and services, including Pharma & Bioanalytical Services, Pharmaceutical Services, Pharmaceutical Third Party Manufacturing, Material Testing Labs & Services, Material Testing Services, Testing Services, Chemical Testing Services, Diagnostic Imaging & Pathology Labs, Medical Test Services, Research and Development (R&D) Work.
Who are the key members and board of directors at Parul Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Parul Patel  | Director | 16-Feb-2021 | Current |
| Devanshu Patel | Director | 16-Feb-2021 | Current |
Financial Performance of Parul Pharmaceuticals.
Parul Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 881.34% increase. The company also saw a substantial improvement in profitability, with a 223.04% increase in profit. The company's net worth Soared by an impressive increase of 310.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Parul Pharmaceuticals?
Unlock access to Parul Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Prayashmay Hospitality Private LimitedActive 2 years 5 monthsParul Patel and Devanshu Patel are mutual person
- Parul Innovation And Entrepreneurship Research CentreActive 9 years 7 months
Parul Patel and Devanshu Patel are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Parul Pharmaceuticals?
Parul Pharmaceuticals has a workforce of 81 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Parul Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Parul Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
